China Arthroscopy Market Size, Share & Trends Analysis Report By Product (Ablation Systems, Visualization Systems, Fluid Management Systems), By Application (Knee, Shoulder, Hip, Elbow), And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 3 Business Days
China Arthroscopy Market Growth & Trends
The China arthroscopy market size is expected treach USD 495.3 million in 2030 and is projected tgrow at a CAGR of 5.0% from 2025 t2030. Increasing incidence of sports injuries, growing prevalence of arthritis is expected tdrive the market over the next few years.
In sports, such as football, basketball, and tennis, knee injuries are most common. Running injuries can result from abrupt stops, tilting, pivoting, jumping, and sharp turns. According tthe MedSci-Clinician Development Platform, sports injuries account for 10% - 20% of all injuries in China and are on the rise. The current rate of sports injuries in China is almost identical tthat of some developed countries, such as the U.S.
Arthroscopy is the most effective treatment for major sports injuries. It is a minimally invasive procedure that is suggested for sports injuries in cases where open surgery is not required. Arthroscopy is commonly performed trepair knee and shoulder injuries, such as ACL tears, SLAP, and Bankart labral tears, meniscus tears, AC joint arthritis and separations, shoulder joint fractures, bursitis, and impingement, torn rotator cuffs, and cartilage damage, and ligament tears. All these factors, thereby, propel the growth of the market.
However, the sudden onset of the COVID-19 pandemic negatively impacted the market. Postponement of surgeries related tknee, shoulder, hip, and other joints resulted in declining sales of arthroscopy devices.
China Arthroscopy Market Report Highlights
China Arthroscopy Market Growth & Trends
The China arthroscopy market size is expected treach USD 495.3 million in 2030 and is projected tgrow at a CAGR of 5.0% from 2025 t2030. Increasing incidence of sports injuries, growing prevalence of arthritis is expected tdrive the market over the next few years.
In sports, such as football, basketball, and tennis, knee injuries are most common. Running injuries can result from abrupt stops, tilting, pivoting, jumping, and sharp turns. According tthe MedSci-Clinician Development Platform, sports injuries account for 10% - 20% of all injuries in China and are on the rise. The current rate of sports injuries in China is almost identical tthat of some developed countries, such as the U.S.
Arthroscopy is the most effective treatment for major sports injuries. It is a minimally invasive procedure that is suggested for sports injuries in cases where open surgery is not required. Arthroscopy is commonly performed trepair knee and shoulder injuries, such as ACL tears, SLAP, and Bankart labral tears, meniscus tears, AC joint arthritis and separations, shoulder joint fractures, bursitis, and impingement, torn rotator cuffs, and cartilage damage, and ligament tears. All these factors, thereby, propel the growth of the market.
However, the sudden onset of the COVID-19 pandemic negatively impacted the market. Postponement of surgeries related tknee, shoulder, hip, and other joints resulted in declining sales of arthroscopy devices.
China Arthroscopy Market Report Highlights
- The ablation systems segment accounted for the largest share of 91.6% in 2024 on account of a rising prevalence of chronic pain disorders such as osteoporosis and arthritis, and preference for minimally invasive surgeries
- The knee segment dominated the China arthroscopy market in 2024. Increasing prevalence of knee arthritis, technological advancements, and rapid adoption of arthroscopes in joint replacement surgeries for precision are major factors likely tdrive the segment
- The arthroscopes segment is expected tgrow at a CAGR of 7.0% from 2025 t2030. Technological advancements coupled with a growing inclination for non-invasive surgical procedures is expected tpropel segment growth over the projected period
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. CHINA ARTHROSCOPY MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
CHAPTER 4. CHINA ARTHROSCOPY MARKET: PRODUCT BUSINESS ANALYSIS
4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Powered Shaver Systems
4.4.1. Powered shaver systems market, 2018 - 2030 (USD Million)
4.5. Visualization Systems
4.5.1. Visualization Systems market, 2018 - 2030 (USD Million)
4.6. Fluid Management Systems
4.6.1. Fluid management systems market, 2018 - 2030 (USD Million)
4.7. Ablation Systems
4.7.1. Ablation systems market, 2018 - 2030 (USD Million)
4.8. Arthroscopes
4.8.1. Arthroscopes market, 2018 - 2030 (USD Million)
4.9. Arthroscope Implants
4.9.1. Arthroscope implants market, 2018 - 2030 (USD Million)
4.10. Accessories and Disposables
4.10.1. Accessories and disposables market, 2018 - 2030 (USD Million)
CHAPTER 5. CHINA ARTHROSCOPY MARKET: APPLICATION BUSINESS ANALYSIS
5.1. Application Market Share, 2024 & 2030
5.2. Application Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Hip
5.4.1. Hip market, 2018 - 2030 (USD Million)
5.5. Knee
5.5.1. Knee market, 2018 - 2030 (USD Million)
5.6. Shoulder
5.6.1. Shoulder market, 2018 - 2030 (USD Million)
5.7. Foot & Ankle
5.7.1. Foot & ankle market, 2018 - 2030 (USD Million)
5.8. Hand & Wrist
5.8.1. Hand & wrist market, 2018 - 2030 (USD Million)
5.9. Elbow
5.9.1. Elbow market, 2018 - 2030 (USD Million)
5.10. Others
5.10.1. Others market, 2018 - 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Participant Overview
6.2. Company Market Position Analysis
6.3. Company Categorization
6.4. Strategy Mapping
6.5. Company Profiles/Listing
6.5.1. Zhejiang Shendasiao Medical Instrument Co., Ltd.
6.5.1.1. Overview
6.5.1.2. Financial performance
6.5.1.3. Product benchmarking
6.5.1.4. Strategic initiatives
6.5.2. TITMED
6.5.2.1. Overview
6.5.2.2. Financial performance
6.5.2.3. Product benchmarking
6.5.2.4. Strategic initiatives
6.5.3. Shrek
6.5.3.1. Overview
6.5.3.2. Financial performance
6.5.3.3. Product benchmarking
6.5.3.4. Strategic initiatives
6.5.4. Xuzhou Hengjia Electronic Technology Co., Ltd.
6.5.4.1. Overview
6.5.4.2. Financial performance
6.5.4.3. Product benchmarking
6.5.4.4. Strategic initiatives
6.5.5. Tonglu Wanhe Medical Instrument Co., Ltd.
6.5.5.1. Overview
6.5.5.2. Financial performance
6.5.5.3. Product benchmarking
6.5.5.4. Strategic initiatives
6.5.6. Stryker
6.5.6.1. Overview
6.5.6.2. Financial performance
6.5.6.3. Product benchmarking
6.5.6.4. Strategic initiatives
6.5.7. Smith & Nephew plc
6.5.7.1. Overview
6.5.7.2. Financial performance
6.5.7.3. Product benchmarking
6.5.7.4. Strategic initiatives
6.5.8. Zimmer Biomet
6.5.8.1. Overview
6.5.8.2. Financial performance
6.5.8.3. Product benchmarking
6.5.8.4. Strategic initiatives
6.5.9. Johnson & Johnson
6.5.9.1. Overview
6.5.9.2. Financial performance
6.5.9.3. Product benchmarking
6.5.9.4. Strategic initiatives
6.5.10. Arthrex, Inc.
6.5.10.1. Overview
6.5.10.2. Financial performance
6.5.10.3. Product benchmarking
6.5.10.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. CHINA ARTHROSCOPY MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
CHAPTER 4. CHINA ARTHROSCOPY MARKET: PRODUCT BUSINESS ANALYSIS
4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Powered Shaver Systems
4.4.1. Powered shaver systems market, 2018 - 2030 (USD Million)
4.5. Visualization Systems
4.5.1. Visualization Systems market, 2018 - 2030 (USD Million)
4.6. Fluid Management Systems
4.6.1. Fluid management systems market, 2018 - 2030 (USD Million)
4.7. Ablation Systems
4.7.1. Ablation systems market, 2018 - 2030 (USD Million)
4.8. Arthroscopes
4.8.1. Arthroscopes market, 2018 - 2030 (USD Million)
4.9. Arthroscope Implants
4.9.1. Arthroscope implants market, 2018 - 2030 (USD Million)
4.10. Accessories and Disposables
4.10.1. Accessories and disposables market, 2018 - 2030 (USD Million)
CHAPTER 5. CHINA ARTHROSCOPY MARKET: APPLICATION BUSINESS ANALYSIS
5.1. Application Market Share, 2024 & 2030
5.2. Application Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Hip
5.4.1. Hip market, 2018 - 2030 (USD Million)
5.5. Knee
5.5.1. Knee market, 2018 - 2030 (USD Million)
5.6. Shoulder
5.6.1. Shoulder market, 2018 - 2030 (USD Million)
5.7. Foot & Ankle
5.7.1. Foot & ankle market, 2018 - 2030 (USD Million)
5.8. Hand & Wrist
5.8.1. Hand & wrist market, 2018 - 2030 (USD Million)
5.9. Elbow
5.9.1. Elbow market, 2018 - 2030 (USD Million)
5.10. Others
5.10.1. Others market, 2018 - 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Participant Overview
6.2. Company Market Position Analysis
6.3. Company Categorization
6.4. Strategy Mapping
6.5. Company Profiles/Listing
6.5.1. Zhejiang Shendasiao Medical Instrument Co., Ltd.
6.5.1.1. Overview
6.5.1.2. Financial performance
6.5.1.3. Product benchmarking
6.5.1.4. Strategic initiatives
6.5.2. TITMED
6.5.2.1. Overview
6.5.2.2. Financial performance
6.5.2.3. Product benchmarking
6.5.2.4. Strategic initiatives
6.5.3. Shrek
6.5.3.1. Overview
6.5.3.2. Financial performance
6.5.3.3. Product benchmarking
6.5.3.4. Strategic initiatives
6.5.4. Xuzhou Hengjia Electronic Technology Co., Ltd.
6.5.4.1. Overview
6.5.4.2. Financial performance
6.5.4.3. Product benchmarking
6.5.4.4. Strategic initiatives
6.5.5. Tonglu Wanhe Medical Instrument Co., Ltd.
6.5.5.1. Overview
6.5.5.2. Financial performance
6.5.5.3. Product benchmarking
6.5.5.4. Strategic initiatives
6.5.6. Stryker
6.5.6.1. Overview
6.5.6.2. Financial performance
6.5.6.3. Product benchmarking
6.5.6.4. Strategic initiatives
6.5.7. Smith & Nephew plc
6.5.7.1. Overview
6.5.7.2. Financial performance
6.5.7.3. Product benchmarking
6.5.7.4. Strategic initiatives
6.5.8. Zimmer Biomet
6.5.8.1. Overview
6.5.8.2. Financial performance
6.5.8.3. Product benchmarking
6.5.8.4. Strategic initiatives
6.5.9. Johnson & Johnson
6.5.9.1. Overview
6.5.9.2. Financial performance
6.5.9.3. Product benchmarking
6.5.9.4. Strategic initiatives
6.5.10. Arthrex, Inc.
6.5.10.1. Overview
6.5.10.2. Financial performance
6.5.10.3. Product benchmarking
6.5.10.4. Strategic initiatives
